Articles

The 3 Best EV Stocks to Buy in December

Sales of Ford's (F) F150 Lightning reached a monthly record in November. Here are three great EV stocks to buy. More

Why Is Carbon Revolution (CREV) Stock Down Today?

Carbon Revolution stock is falling on Wednesday after shares of CREV gained yesterday with plans for a business update conference call. More

Flying High: 3 Stocks to Invest in the Up-and-Coming eVTOL Aircraft Sector

If you want to try your hand at compelling innovation but are tired of researching the next big idea for artificial intelligence, you might consider electric vertical takeoff and landing or eVTOL stocks. Representing the next wave of mobility, eVTOL effectively combine the advancements undergirding helicopters, airplanes and electric vehicles. From a social impact standpoint,… More

3 Hot Stocks to Hold On to for Long-Term Growth

While enterprises focused on expanding the top line tend to cater to a short-and-sweet methodology, compelling long-term growth stocks to buy and hold may reward speculators that are not necessarily in a big hurry. Over time, these ideas could lead to significant gains. Plus, they have advantages that many flavors of the week lack. First… More

The 3 Best EV Charging Stocks to Buy in December

EV charging stocks have faltered, but these 3 offer strong return potential moving forward for investors willing to risk it. More

7 Cryptos to Watch as the Blockchain Encounters an Oddity

Although cryptos to watch have skyrocketed, instilling a dramatic confidence boost in the underlying blockchain ecosystem, we also have to ask the natural question: why? Of course, a major reason centers on the speculation of an imminent approval for a spot-crypto exchange-traded fund. However, broader speculation about monetary policy also undergirds sentiment. In particular, investors… More

Why Is ImmunoPrecise Antibodies (IPA) Stock Down 39% Today?

ImmunoPrecise Antibodies stock is falling on Wednesday after the company announced a $1.1 million public offering for shares of IPA. More